The government has launched a national campaign urging cat and dog owners to take greater care when using flea and tick spot-on treatments, after evidence that residues from some products are reaching rivers and streams. The intervention sits at the meeting point of animal health, retail regulation and environmental protection, and is aimed at changing how routine treatments are applied rather than discouraging their use. According to the Veterinary Medicines Directorate, spot-on products remain an important defence against parasites and the diseases they can spread. The official position is that these medicines should continue to be used where needed, but in closer accordance with product instructions so that protection for pets and people does not come with avoidable environmental harm.
The evidence behind the campaign centres on two active ingredients commonly found in flea and tick products: fipronil and imidacloprid. Environment Agency monitoring has detected both substances in UK waterways at levels that could harm aquatic insects, including mayflies and dragonflies, which are often treated as markers of freshwater condition. Research funded by the Veterinary Medicines Directorate indicates that these chemicals can reach waterways through wastewater and when recently treated animals enter natural water. That risk is material because spot-on medicines are used across a pet population of roughly 21 million cats and dogs in the UK, making small changes in behaviour potentially significant at national scale.
The public guidance has been framed around a simple sequence: plan, apply, protect. In practice, that means owners are being asked to think about timing before treatment starts, including washing an animal in the days before application rather than afterwards and choosing a point when close contact can be reduced while the product dries. The Veterinary Medicines Directorate is also stressing application technique. Owners are being told to read the leaflet or check the Product Information Database, part the fur so the liquid reaches the skin rather than the coat, avoid touching the treated area until it is dry, keep pets out of natural waters for at least four days after treatment, and dispose of used pipettes, treated fur and unused medicine through the correct waste route rather than sinks, recycling or outdoor disposal.
For policy readers, this is not a standalone awareness exercise. The campaign sits within the government's broader Pharmaceuticals in the Environment programme, which is examining how medicines used in human and animal settings move beyond their intended point of use and into the natural environment. The cross-government Pharmaceuticals in the Environment Group has already published a roadmap on chemicals from pet flea and tick treatments in waterways. This campaign is the immediate delivery element of that work, aimed at reducing emissions now while departments and regulators continue to develop the evidence base for longer-term decisions on product supply, product information and usage controls.
A more formal regulatory question is running alongside the campaign. The Veterinary Medicines Directorate has opened a distribution category review for veterinary medicines containing fipronil and imidacloprid, and the review is considering whether professional advice should be required at the point of sale. The call for evidence opened on 16 April 2026 and closes on 11 June 2026. If that process results in tighter sales conditions, the effect would extend beyond manufacturers to vets, retailers, groomers, medicines suppliers and pet owners, particularly where these products are currently bought as routine over-the-counter treatments.
The official statements issued with the campaign have been careful to balance access with control. Abigail Seager, chief executive of the Veterinary Medicines Directorate, presented spot-on medicines as important for protecting both animal and human health while acknowledging that residues are reaching waterways. Supporting comments from RUMA Companion Animal and Equine and from Professor Jason Weeks, chair of the Pharmaceuticals in the Environment Group, place the campaign within a responsible-use framework rather than a move to withdraw treatment options. That framing is important. It signals that ministers and regulators are not questioning the public health value of parasite control as such, but are focusing on how products are used, how they are supplied, and whether existing consumer purchasing arrangements still fit the available environmental evidence.
The practical message for households is that owners who cannot follow the precautions, or who think a treatment is not working, should seek advice from a vet or medicine supplier rather than simply repeating use. That is particularly relevant for pets that swim regularly, require frequent washing, or live in households where close contact after treatment is difficult to avoid. The government has also published a dedicated campaign site and free communications materials for vets, retailers and groomers. For the veterinary and retail sectors, the next phase is both operational and consultative: behaviour change is being encouraged immediately, while the open call for evidence tests whether voluntary action is enough or whether products containing fipronil and imidacloprid should move closer to a professionally advised sales model.